FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Sudarshan Pharma IPO.
April 5, 2024 3:30:00 AM
Sudarshan Pharma Industries Ltd share price was up by 2.11% from the previous closing price of ?78.49. Who are peers of Sudarshan Pharma Industries Ltd? The peers of Sudarshan Pharma Industries ...
Published by : Business TodayApril 24, 2024 4:57:00 AM
Executives at a bubble-tea company struck the gong Tuesday morning for Hong Kong�s biggest IPO yet this year. Then silence descended on the listing hall. Shares of Sichuan-based ChaPanda opened 10% ...
Published by : Wall Street JournalMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechJanuary 29, 2015 3:13:00 PM
If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close. If the biotech bull market hasn't reached 11 on the absurdity meter quite yet ...
Published by : TheStreet.comMay 8, 2023 9:53:00 AM
The IPO was issued at Rs 1,080 with a price range of Rs 1,026-1,080 per share, and a lot of Mankind Pharma comprised of 13 shares. The IPO received an overwhelming response from investors ...
Published by : MSNMay 12, 2020 3:30:00 AM
LTRN believes it can better stratify patient populations for improved trial results for previously failed Phase 3 trials drug candidates. LTRN believes it can better stratify patient populations ...
Published by : TheStreet.comJune 17, 2020 3:30:00 AM
The scale of the IPO � which is the largest in the US this year across all industrial sectors � reflects Royalty Pharma�s position as the largest player in the niche area of pharmaceutical ...
Published by : pharmaphorumApril 19, 2024 1:00:00 AM
Experts said that key categories such as generic formulations (73% of total exports) and API (active pharmaceuticals ingredients) categories witnessed robust growth from critical markets such as US, ...
Published by : The Financial Express on MSNFebruary 3, 2024 8:13:00 PM
In 2023, the losses delivered by nearly all European IPOs made for a tiny shortlist for this award, but German specialist glassmaker Schott Pharma would shine in any year. In a year of crashing ...
Published by : International Financing ReviewApril 26, 2024 12:11:00 AM
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is ...
Published by : Seeking AlphaApril 18, 2024 7:30:00 PM
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women�s cancers. Its lead product candidate ...
Published by : Seeking AlphaSudarshan Pharma Industries Limited is entering in the capital market with an IPO of 3,440,000 Equity Shares of Rs 10 aggregating up to Rs 24.77 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The issue opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME.
The issue of Sudarshan Pharma Industries Limited opens on Jun 12, 2019 and closes for subscription on Jun 24, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Sudarshan Pharma IPO is proposed to open on June 12, 2019. The IPO application ends on June 21, 2019.
Retail investors can apply in the retail or non-institutional investor category from June 12, 2019 to June 21, 2019. The Sudarshan Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Sudarshan Pharma IPO will open for subscription on June 12, 2019. The public issue will close on June 21, 2019.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|